Brian C. Davis, M.D., and Amit G. Singal, M.D., M.S.
Dr. Davis Is Resident Physician and Dr. Singal is Associate Professor, Medical Director of Liver Tumor Program, Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX.
Within the past 12 months, Dr Davis has no conflicts of interest relevant to this activity. Dr. Singal is on the speaker’s bureau for Bayer, consulted for Bayer and Wako Diagnostics and has received research support from Gilead.
Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose relevant to this activity.
Release Date: 04/03/2016
Upon completion of this Cyberounds®, you should be able to:
List and discuss effective methods for prevention and early detection of HCC in patients with cirrhosis;
Recommend treatment options for patients with cirrhosis and HCC at all stages – early stage, intermediate stage, advanced stage, and terminal stage;
Integrate the role of multidisciplinary care for treatment of patients with HCC.
